Efficacy and Safety of Tofacitinib, Baricitinib, and Upadacitinib for Rheumatoid Arthritis: A Systematic Review and Meta-Analysis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Efficacy and Safety of Tofacitinib, Baricitinib, and Upadacitinib for Rheumatoid Arthritis: A Systematic Review and Meta-Analysis

Published:2020-07 Issue:7 Volume:95 Page:1404-1419
ISSN:0025-6196
Container-title:Mayo Clinic Proceedings
language:en
Short-container-title:Mayo Clinic Proceedings

Author:

Wang Faping,Sun Ling,Wang Shaohua,Davis John M.,Matteson Eric L.,Murad M. Hassan^ORCID,Luo Fengming,Vassallo Robert^ORCID

Funder

National Nature Science Foundation of China

Ministry of Science and Technology of the People's Republic of China

Science and Technology Support Program of Sichuan province

Chengdu Science and Technology Bureau

Pfizer

Bristol Myers Squibb

Sun Pharmaceuticals

Boehringer-Ingelheim

Publisher

Elsevier BV

Subject

General Medicine

Reference57 articles.

1. Recent advances in the treatment of rheumatoid arthritis;Mahajan;Curr Opin Rheumatol,2018

2. New alternative in the treatment of rheumatoid arthritis: clinical utility of baricitinib;Kawalec;Ther Clin Risk Manag,2019

3. Prevalence of rheumatoid arthritis in the United States adult population in healthcare claims databases, 2004-2014;Hunter;Rheumatol Int,2017

4. The incidence of rheumatoid arthritis in the UK: comparisons using the 2010 ACR/EULAR classification criteria and the 1987 ACR classification criteria. Results from the Norfolk Arthritis Register;Humphreys;Ann Rheum Dis,2013

5. JAK-inhibitors. New players in the field of immune-mediated diseases, beyond rheumatoid arthritis;Fragoulis;Rheumatology (Oxford),2019

Cited by 72 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effect of disease duration on the use of tofacitinib: a real-world study in elderly patients with rheumatoid arthritis;Clinical Rheumatology;2024-08-02

2. A narrative review of the comparative safety of disease-modifying anti-rheumatic drugs used for the treatment of rheumatoid arthritis;Expert Opinion on Drug Safety;2024-05-23

3. Activation of Janus kinase 2 contributes to the autoimmune pathology in the salivary glands of patients with Sjögren's syndrome;Oral Science International;2024-04-18

4. Stroke risk in rheumatoid arthritis patients: exploring connections and implications for patient care;Clinical and Experimental Medicine;2024-01-31

5. Safety of Upadacitinib in Immune-Mediated Inflammatory Diseases: Systematic Literature Review of Indirect and Direct Treatment Comparisons of Randomized Controlled Trials;Advances in Therapy;2024-01-02

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3